ClinicalTrials.gg
RecruitingNCT07877480PRIMEUpdated Oct 16, 2026

Predicting High-Risk Carotid Plaque: Integrating radioMics and biomEchanics

An interventional study of Radiomic features analysis in Carotid Artery and Carotid Arteriosclerosis, sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Sep 2025, registered Oct 2026).
  • Started Sep 2025; still recruiting 1 year 1 month later.
Updated Oct 16, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
420
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Non-pharmacological interventional study for the development of a predictive model aimed at identifying unstable carotid plaques in asymptomatic patients at first diagnosis, with the use of biological material and prospective-retrospective data collection

Read the detailed description

Stroke is a leading cause of mortality and morbidity globally, accounting for 12 million cases worldwide in 2019 and a global cost of $891 billion in 2017. One of the main causes of stroke is the rupture of atheromatous plaque in the carotid artery. For this reason, identifying and studying plaques is essential to preventing stroke and cerebrovascular events.

European guidelines recommend risk stratification strategies for carotid plaques based on the degree of stenosis they cause and the assessment, through radiological imaging, of their core characteristics. However, this stratification alone is still not enough. In recent years, scientific research has succeeded in identifying additional markers of instability in the morphological and compositional characteristics of plaques based on imagery.

Finally, radiomics, a new field of high-throughput extraction of quantitative features observable in radiological images, has demonstrated promising results in recognizing and stratifying unstable carotid plaques.

The overall aim of the study is to create a predictive model that aims to identify unstable plaques in asymptomatic patients at initial diagnosis. Currently, the most effective objective method for assessing plaque instability is histopathological analysis, but this is only available after surgery. Therefore, it is crucial to have a noninvasive predictive model for identifying the risk of cerebrovascular accidents in asymptomatic patients.

Specifically, the primary objective is to identify carotid plaque instability by extracting radiomic markers belonging to the "shape and size" (26 shape and size features), "first-order statistics" (19 statistical features), and "textural" (75 texture features) classes from each CTA image. A further objective will be the calculation of mechanical markers (von Mises stress, maximum principal stress, ultimate stress, and thickness) capable of identifying carotid plaque instability in patients with carotid stenosis and candidates for carotid artery stenosis surgical removal.

The study will involve patients attending the Foundation's Vascular Surgery Unit and candidates for carotid artery stenosis. Two specific phases are planned. The first phase will be retrospective and will involve the retrieval of clinical and imaging data to activate machine learning for the analysis of radiomics data in combination with clinical data. Preoperative CT images and perioperative clinical data will be analyzed for training and preliminary development of a machine learning model based on radiomics, clinical, and biomechanical data, calculated from structural and fluid dynamics numerical simulations. Patient-specific preoperative CT images will be segmented using 2D convolutional neural networks (CNNs). The resulting 3D models of vessels and plaques will be used for structural and fluid dynamic simulations and radiomics analysis.

In the second prospective phase, patients will be enrolled consecutively, according to the SOC's indication for surgery. After obtaining written informed consent, the inclusion/exclusion criteria will be evaluated and each patient will be assigned a progressive identification code. Preoperative clinical and imaging (CT) data will be collected. The prospectively enrolled patients will undergo the same procedure (carotid TEA), according to the protocols and standards proposed by the European Society of Vascular Surgery (ESVS) and adopted in common clinical practice by our SC.

At the end of the TEA procedure, in addition to collecting pre- and post-operative clinical data, histopathological and biomechanical analysis of the surgically removed plaque, which is usually not analyzed and disposed of, will be performed. The results will be used to prepare and validate the virtual predictive model. The surgeon will send the removed material, in alternating sequence, once for histology and once for mechanical testing. Subsequently, numerical strategies will be adopted to calculate the biomechanics of carotid arteries affected by the presence of plaque. In addition to these numerical approaches, a machine learning algorithm will be used to couple the previously identified variables (i.e., morphological, histological, radiomic, and biomechanical) to identify markers capable of identifying unstable plaques.

Finally, 3D printing will be used to produce anatomical and functional models of the segmented geometries of patients undergoing TEA. These prints will be inserted into a hydraulic circuit capable of reproducing physiopathological flow and pressure conditions. This strategy will be used to validate the results from the structural and fluid dynamic simulations in a fully controlled environment in terms of postoperative geometric conformation (postoperative diameters achieved by the anatomy) and flow distribution at the fluid dynamic level.

02

Conditions studied

  • Carotid Artery
  • Carotid Arteriosclerosis

Keywords

  • carotid endarterectomy
  • Carotid Artery Disease
03

In context

Carotid Artery Diseases

257 studies on the registry are indexed under Carotid Artery Diseases; 58 are open to participants now.

This study's planned enrollment of 420 is above the median of 120 across 123 interventional studies indexed under Carotid Artery Diseases.

Browse Carotid Artery Diseases studies →

Lead sponsor

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico is the lead sponsor of 232 studies on the registry; 83 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients ≥ 18 years of age;
  • Affected by significant carotid atherosclerosis, whether symptomatic or asymptomatic (stenosis ≥ 70% according to ECST criteria).
  • Candidates for carotid ATE surgery. The criteria provided by the SICVE and ESVS guidelines will be followed for indications for surgery;
  • Preoperative imaging available;

Exclusion criteria

Exclusion Criteria:

  • Patients who have undergone previous carotid endarterectomy (ipsilateral to the affected side);
  • Patients who have undergone previous neck surgery involving cervical lymph node dissection;
  • Patients who have undergone previous neck radiation therapy;
  • Lack of preoperative imaging;
  • Patients unable to sign informed consent.
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
420 participants (estimated)

Study arms

  • Other
    Radiomic Analysis

    Diagnostic Test: Radiomic features analysis

Interventions

  • Diagnostic testRadiomic features analysis

    Identification of carotid plaque instability by extracting radiomic markers belonging to the "shape and size" (26 shape and size features), "first order statistics" (19 statistical features) and "textural" (75 texture features) classes from each CTA image

06

What researchers measure

Primary outcomes

  1. Radiomic markers

    Identification form CT scan images of a radiomic marker predictive of plaque instability, with an AUC ≥ 0.85.

    Time frame: at enrollment

Secondary outcomes

  1. Plaque mechanical markers

    Measurement of the Von Mises stress absorbed by the plate in MPa

    Time frame: 24 hours post-op

07

Study locations

1 of 1 sites recruiting
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Milan, Italy
    Recruiting
08

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07877480
Collaborators
University of Pavia
Responsible party
Maurizio Domanin (Prof., Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico) — Principal investigator
First posted
Oct 16, 2026
Start date
Sep 1, 2025
Primary completion
Sep 30, 2026
Completion
Dec 30, 2026 (estimated)
Last update
Oct 16, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion